PERRIGO CO PLC (PRGO) Stock Fundamental Analysis
NYSE:PRGO - IE00BGH1M568 - Common Stock
23.525 USD
-0.21 (-0.91%)
Taking everything into account, PRGO scores 5 out of 10 in our fundamental rating. PRGO was compared to 195 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of PRGO while its profitability can be described as average. PRGO is valued quite cheap, while showing a decent growth score. This is a good combination! PRGO also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
PRGO had positive earnings in the past year.
In the past year PRGO had a positive cash flow from operations.
PRGO had negative earnings in each of the past 5 years.
In the past 5 years PRGO always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.80%, PRGO is in the better half of the industry, outperforming 78.46% of the companies in the same industry.
Looking at the Return On Equity, with a value of -1.80%, PRGO is in the better half of the industry, outperforming 79.49% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.64%, PRGO is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PRGO is significantly below the industry average of 15.28%.
The 3 year average ROIC (2.21%) for PRGO is below the current ROIC(3.64%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.8% | ||
| ROE | -1.8% | ||
| ROIC | 3.64% |
ROA(3y)-1.06%
ROA(5y)-1.05%
ROE(3y)-2.38%
ROE(5y)-2.27%
ROIC(3y)2.21%
ROIC(5y)2.9%
1.3 Margins
Looking at the Operating Margin, with a value of 9.55%, PRGO belongs to the top of the industry, outperforming 82.05% of the companies in the same industry.
PRGO's Operating Margin has improved in the last couple of years.
The Gross Margin of PRGO (35.73%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of PRGO has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.55% | ||
| PM (TTM) | N/A | ||
| GM | 35.73% |
OM growth 3Y-22.79%
OM growth 5Y3.71%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y-0.98%
2. Health
2.1 Basic Checks
PRGO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PRGO has more shares outstanding
Compared to 5 years ago, PRGO has more shares outstanding
The debt/assets ratio for PRGO has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.77, we must say that PRGO is in the distress zone and has some risk of bankruptcy.
PRGO has a Altman-Z score of 0.77. This is comparable to the rest of the industry: PRGO outperforms 56.92% of its industry peers.
PRGO has a debt to FCF ratio of 14.23. This is a negative value and a sign of low solvency as PRGO would need 14.23 years to pay back of all of its debts.
PRGO has a better Debt to FCF ratio (14.23) than 77.95% of its industry peers.
A Debt/Equity ratio of 0.81 indicates that PRGO is somewhat dependend on debt financing.
PRGO has a Debt to Equity ratio of 0.81. This is in the lower half of the industry: PRGO underperforms 70.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 14.23 | ||
| Altman-Z | 0.77 |
ROIC/WACC0.5
WACC7.3%
2.3 Liquidity
PRGO has a Current Ratio of 2.32. This indicates that PRGO is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PRGO (2.32) is comparable to the rest of the industry.
PRGO has a Quick Ratio of 1.24. This is a normal value and indicates that PRGO is financially healthy and should not expect problems in meeting its short term obligations.
PRGO's Quick ratio of 1.24 is on the low side compared to the rest of the industry. PRGO is outperformed by 68.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 25.43% over the past year.
Measured over the past years, PRGO shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.68% on average per year.
The Revenue has decreased by -2.31% in the past year.
PRGO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.48% yearly.
EPS 1Y (TTM)25.43%
EPS 3Y7.69%
EPS 5Y-8.68%
EPS Q2Q%7.55%
Revenue 1Y (TTM)-2.31%
Revenue growth 3Y1.86%
Revenue growth 5Y2.48%
Sales Q2Q%-0.86%
3.2 Future
The Earnings Per Share is expected to grow by 8.85% on average over the next years. This is quite good.
PRGO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.28% yearly.
EPS Next Y19.03%
EPS Next 2Y11.67%
EPS Next 3Y10.46%
EPS Next 5Y8.85%
Revenue Next Year-1.04%
Revenue Next 2Y-0.25%
Revenue Next 3Y0.51%
Revenue Next 5Y1.28%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 8.08 indicates a reasonable valuation of PRGO.
Based on the Price/Earnings ratio, PRGO is valued cheaply inside the industry as 92.82% of the companies are valued more expensively.
PRGO's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.13.
PRGO is valuated cheaply with a Price/Forward Earnings ratio of 7.37.
Based on the Price/Forward Earnings ratio, PRGO is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of PRGO to the average of the S&P500 Index (22.76), we can say PRGO is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.08 | ||
| Fwd PE | 7.37 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PRGO indicates a rather cheap valuation: PRGO is cheaper than 89.23% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, PRGO is valued cheaply inside the industry as 88.72% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.61 | ||
| EV/EBITDA | 8.71 |
4.3 Compensation for Growth
PRGO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y11.67%
EPS Next 3Y10.46%
5. Dividend
5.1 Amount
PRGO has a Yearly Dividend Yield of 4.88%, which is a nice return.
Compared to an average industry Dividend Yield of 5.73, PRGO pays a better dividend. On top of this PRGO pays more dividend than 96.92% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, PRGO pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.88% |
5.2 History
On average, the dividend of PRGO grows each year by 6.29%, which is quite nice.
PRGO has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of PRGO decreased recently.
Dividend Growth(5Y)6.29%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
The earnings of PRGO are negative and hence is the payout ratio. PRGO will probably not be able to sustain this dividend level.
PRGO's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-195.14%
EPS Next 2Y11.67%
EPS Next 3Y10.46%
NYSE:PRGO (9/2/2025, 2:09:08 PM)
23.525
-0.21 (-0.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners105.53%
Inst Owner Change-6.67%
Ins Owners0.44%
Ins Owner Change14.03%
Market Cap3.24B
Analysts78
Price Target34.17 (45.25%)
Short Float %4.67%
Short Ratio4.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.88% |
Yearly Dividend1.12
Dividend Growth(5Y)6.29%
DP-195.14%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.81%
Min EPS beat(2)-5.82%
Max EPS beat(2)7.44%
EPS beat(4)1
Avg EPS beat(4)-0.48%
Min EPS beat(4)-5.82%
Max EPS beat(4)7.44%
EPS beat(8)5
Avg EPS beat(8)4.63%
EPS beat(12)8
Avg EPS beat(12)4.32%
EPS beat(16)9
Avg EPS beat(16)-0.21%
Revenue beat(2)0
Avg Revenue beat(2)-5.05%
Min Revenue beat(2)-5.79%
Max Revenue beat(2)-4.32%
Revenue beat(4)0
Avg Revenue beat(4)-5.35%
Min Revenue beat(4)-6.62%
Max Revenue beat(4)-4.32%
Revenue beat(8)0
Avg Revenue beat(8)-5.42%
Revenue beat(12)0
Avg Revenue beat(12)-4.72%
Revenue beat(16)1
Avg Revenue beat(16)-3.62%
PT rev (1m)-8.64%
PT rev (3m)-2.9%
EPS NQ rev (1m)-4.2%
EPS NQ rev (3m)-2.91%
EPS NY rev (1m)-1.81%
EPS NY rev (3m)-1.53%
Revenue NQ rev (1m)-1.49%
Revenue NQ rev (3m)-2.18%
Revenue NY rev (1m)-1.04%
Revenue NY rev (3m)-0.89%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.08 | ||
| Fwd PE | 7.37 | ||
| P/S | 0.75 | ||
| P/FCF | 12.61 | ||
| P/OCF | 8.84 | ||
| P/B | 0.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.71 |
EPS(TTM)2.91
EY12.37%
EPS(NY)3.19
Fwd EY13.57%
FCF(TTM)1.87
FCFY7.93%
OCF(TTM)2.66
OCFY11.31%
SpS31.44
BVpS32.51
TBVpS-11.41
PEG (NY)0.42
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.8% | ||
| ROE | -1.8% | ||
| ROCE | 4.61% | ||
| ROIC | 3.64% | ||
| ROICexc | 3.83% | ||
| ROICexgc | 13.21% | ||
| OM | 9.55% | ||
| PM (TTM) | N/A | ||
| GM | 35.73% | ||
| FCFM | 5.93% |
ROA(3y)-1.06%
ROA(5y)-1.05%
ROE(3y)-2.38%
ROE(5y)-2.27%
ROIC(3y)2.21%
ROIC(5y)2.9%
ROICexc(3y)2.37%
ROICexc(5y)3.33%
ROICexgc(3y)9.14%
ROICexgc(5y)12.63%
ROCE(3y)2.79%
ROCE(5y)3.67%
ROICexcg growth 3Y-27.17%
ROICexcg growth 5Y8.08%
ROICexc growth 3Y-25.01%
ROICexc growth 5Y10.11%
OM growth 3Y-22.79%
OM growth 5Y3.71%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y-0.98%
F-Score5
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 14.23 | ||
| Debt/EBITDA | 4.87 | ||
| Cap/Depr | 33.3% | ||
| Cap/Sales | 2.53% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 49.35% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 0.77 |
F-Score5
WACC7.3%
ROIC/WACC0.5
Cap/Depr(3y)31.02%
Cap/Depr(5y)43.56%
Cap/Sales(3y)2.35%
Cap/Sales(5y)3.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.43%
EPS 3Y7.69%
EPS 5Y-8.68%
EPS Q2Q%7.55%
EPS Next Y19.03%
EPS Next 2Y11.67%
EPS Next 3Y10.46%
EPS Next 5Y8.85%
Revenue 1Y (TTM)-2.31%
Revenue growth 3Y1.86%
Revenue growth 5Y2.48%
Sales Q2Q%-0.86%
Revenue Next Year-1.04%
Revenue Next 2Y-0.25%
Revenue Next 3Y0.51%
Revenue Next 5Y1.28%
EBIT growth 1Y104.45%
EBIT growth 3Y-21.35%
EBIT growth 5Y6.28%
EBIT Next Year41.27%
EBIT Next 3Y15.82%
EBIT Next 5Y10.05%
FCF growth 1Y8.54%
FCF growth 3YN/A
FCF growth 5Y19.35%
OCF growth 1Y15.37%
OCF growth 3Y32.42%
OCF growth 5Y-1.32%